InspireMD shares rise 15.59% intraday after announcing inducement grants of 122,054 restricted shares for eight new employees under 2024 plan.

InspireMD (NSPR) surged 15.59% intraday following the announcement of inducement grants totaling 122,054 restricted shares to eight new non-executive employees under its 2024 Inducement Plan. The grants, issued outside the 2021 Equity Incentive Plan and compliant with Nasdaq Listing Rule 5635(c)(4), vest over three years, with one-third vesting annually. The move signals the company’s focus on attracting talent to support operational or strategic initiatives, potentially boosting investor confidence in its growth trajectory. The stock’s sharp intraday increase suggests market optimism about the company’s resource allocation and future performance, aligning with the news of expanded workforce incentives.